These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23140189)

  • 1. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents.
    Agrawal R; Jain P; Dikshit SN
    Comb Chem High Throughput Screen; 2012 Dec; 15(10):849-76. PubMed ID: 23140189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors.
    Agrawal R; Jain P; Dikshit SN; Bahare RS
    Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors.
    Upadhyay J; Gajjar A; Suhagia BN
    Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
    Almasri IM; Taha MO; Mohammad MK
    Arch Pharm Res; 2013 Nov; 36(11):1326-37. PubMed ID: 23918649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
    Meduru H; Wang YT; Tsai JJ; Chen YC
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrus bioflavonoids dipeptidyl peptidase-4 inhibition compared with gliptin antidiabetic medications.
    Gupta A; Jacobson GA; Burgess JR; Jelinek HF; Nichols DS; Narkowicz CK; Al-Aubaidy HA
    Biochem Biophys Res Commun; 2018 Sep; 503(1):21-25. PubMed ID: 29698678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
    Mohanty IR; Borde M; Kumar C S; Maheshwari U
    Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors.
    Khalaf RA; Sabbah D; Al-Shalabi E; Al-Sheikh I; Albadawi G; Abu Sheikha G
    Curr Comput Aided Drug Des; 2018; 14(2):142-151. PubMed ID: 29521244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
    Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
    Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
    Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M
    J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combiphore (Structure and Ligand Based Pharmacophore) - Approach for the Design of GPR40 Modulators in the Management of Diabetes.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(2):233-247. PubMed ID: 30306872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
    Shah BM; Modi P; Trivedi P
    J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
    Li G; Huan Y; Yuan B; Wang J; Jiang Q; Lin Z; Shen Z; Huang H
    Eur J Med Chem; 2016 Nov; 124():103-116. PubMed ID: 27560285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study.
    Arulmozhiraja S; Matsuo N; Ishitsubo E; Okazaki S; Shimano H; Tokiwa H
    PLoS One; 2016; 11(11):e0166275. PubMed ID: 27832184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitors.
    Agrawal R; Jain P; Dikshit SN; Jain S
    Protein Pept Lett; 2013 Sep; 20(9):1066-78. PubMed ID: 23607811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of levomenthol derivatives as potential dipeptidyl peptidase-4 inhibitors: a comparative study with gliptins.
    Alade AA; Ahmed SA; Mujwar S; Kikiowo B; Akinnusi PA; Olubode SO; Olufemi OM; Ohilebo AA
    J Biomol Struct Dyn; 2024 May; 42(8):4029-4047. PubMed ID: 37261796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.